| Literature DB >> 22801951 |
Manuel Praga1, Jorge Rojas-Rivera.
Abstract
Several immunosuppressive treatments have demonstrated their efficacy in idiopathic membranous nephropathy, but spontaneous remission does develop in more than 30% of patients. The availability of a validated biomarker that is easy to measure and able to accurately predict long-term outcomes would be very helpful for tailoring treatment of the disease to the individual.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22801951 DOI: 10.1038/nrneph.2012.161
Source DB: PubMed Journal: Nat Rev Nephrol ISSN: 1759-5061 Impact factor: 28.314